We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$39.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$31.2M
3
XEC
CIMAREX ENERGY CO
XEC
+$23.4M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$21.9M
5
SBNY
Signature Bank
SBNY
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MG icon
2826
Mistras Group
MG
$512M
$204K ﹤0.01%
27,468
-946
-3% -$8.32K
STTK icon
2827
Shattuck Labs
STTK
$694M
$204K ﹤0.01%
23,960
-473
-2% -$6.51K
FUV
2828
DELISTED
Arcimoto, Inc. Common Stock
FUV
$204K ﹤0.01%
1,309
-23
-2% -$4.7K
DRRX
2829
DELISTED
DURECT Corp
DRRX
$203K ﹤0.01%
20,636
-496
-2% -$5.48K
PARAA
2830
DELISTED
Paramount Global Class A
PARAA
$203K ﹤0.01%
6,074
-717
-11% -$26.9K
PLSE icon
2831
Pulse Biosciences
PLSE
$3.02B
$202K ﹤0.01%
13,641
-252
-2% -$5.02K
EIGR
2832
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$202K ﹤0.01%
1,297
-21
-2% -$4.06K
EOLS icon
2833
Evolus
EOLS
$501M
$200K ﹤0.01%
30,654
+306
+1% +$2.1K
OYST
2834
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$200K ﹤0.01%
10,963
-213
-2% -$2.7K
KG
2835
Kestrel Group
KG
$69M
$198K ﹤0.01%
3,230
-17
-0.5% -$1.07K
PZN
2836
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$198K ﹤0.01%
20,889
-313
-1% -$3.25K
CRMD icon
2837
CorMedix
CRMD
$584M
$197K ﹤0.01%
43,349
-7
-0% -$35
TECX
2838
Tectonic Therapeutic
TECX
$606M
$197K ﹤0.01%
4,272
-57
-1% -$3.27K
REKR icon
2839
Rekor Systems
REKR
$91.7M
$196K ﹤0.01%
29,874
-559
-2% -$5.26K
DRIO icon
2840
DarioHealth
DRIO
$71.2M
$193K ﹤0.01%
742
-24
-3% -$7.3K
NEUE
2841
DELISTED
NeueHealth
NEUE
$193K ﹤0.01%
701
-5
-0.7% -$2.31K
TNYA icon
2842
Tenaya Therapeutics
TNYA
$163M
$192K ﹤0.01%
10,152
-70
-0.7% -$1.52K
INFU icon
2843
InfuSystem Holdings
INFU
$249M
$191K ﹤0.01%
11,211
-319
-3% -$5.06K
VOXX
2844
DELISTED
VOXX International Corporation Class A
VOXX
$191K ﹤0.01%
18,770
-575
-3% -$6.39K
LTRPA
2845
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$191K ﹤0.01%
88,153
-1,576
-2% -$4.45K
AXDX
2846
DELISTED
Accelerate Diagnostics
AXDX
$190K ﹤0.01%
3,644
-20
-0.5% -$1.11K
CASA
2847
DELISTED
Casa Systems, Inc. Common Stock
CASA
$190K ﹤0.01%
33,576
+1,693
+5% +$9.8K
APPH
2848
DELISTED
AppHarvest, Inc. Common Stock
APPH
$190K ﹤0.01%
48,927
-1,226
-2% -$6.55K
LUNA
2849
DELISTED
Luna Innovations Incorporated
LUNA
$185K ﹤0.01%
21,913
-541
-2% -$4.85K
ARIS
2850
DELISTED
Aris Water Solutions
ARIS
$184K ﹤0.01%
+14,227
New +$189K
112 113
114
115 116

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.